Investigating treatments for post-hemorrhagic hydrocephalus in the brain.
Targeting the Choroid Plexus-Cerebrospinal Fluid System to Treat Post-Hemorrhagic Hydrocephalus
This study is looking at ways to help premature babies with post-hemorrhagic hydrocephalus, a condition caused by bleeding in the brain, by figuring out how to better manage the fluid in their brains and reduce damage, which could lead to new treatments for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11178723 on NIH RePORTER |
What this research studies
This research focuses on understanding and treating post-hemorrhagic hydrocephalus (PHH), a condition that can occur in premature infants due to bleeding in the brain. The study aims to explore how the choroid plexus, which produces cerebrospinal fluid (CSF), and macrophages, which help clear blood from the ventricles, can be manipulated to improve CSF balance and reduce brain damage. By examining the mechanisms behind CSF production and removal, the research seeks to develop targeted therapies that could alleviate the effects of PHH. Patients may benefit from new treatment options that arise from this understanding.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who have experienced complications related to post-hemorrhagic hydrocephalus or similar cerebrospinal fluid imbalances.
Not a fit: Patients with hydrocephalus not related to hemorrhagic events or those with other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that significantly improve outcomes for patients suffering from post-hemorrhagic hydrocephalus.
How similar studies have performed: While the specific approach of targeting the choroid plexus for PHH is novel, similar strategies in other conditions have shown promise in improving patient outcomes.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Lehtinen, Maria — Boston Children's Hospital
- Study coordinator: Lehtinen, Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.